文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

脑死亡器官捐献者重症管理中的升压药选择与移植肾功能的关系

Vasopressor selection during critical care management of brain dead organ donors and the effects on kidney graft function.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论在脑死亡器官捐献者中,较高剂量的去氧肾上腺素是移植肾延迟恢复(DGF)的独立预测因素,其他升压药选择及剂量未预测DGF。

该前瞻性观察研究纳入2012至2018年9个器官获取与移植网络区域17个器官获取组织管理的2985例脑死亡器官捐献者及5554例肾移植受者,记录捐献者重症管理期间三个标准化时间点的升压药类型和剂量,并转换为去甲肾上腺素等效剂量。单因素分析显示捐献者血清肌酐、年龄、捐献者亚型、肾捐献者特征指数、移植物冷缺血时间、去氧肾上腺素剂量和多巴胺剂量与DGF相关;多因素分析后,捐献者血清肌酐升高、年龄、肾捐献者特征指数、移植物冷缺血时间和去氧肾上腺素剂量仍是DGF的独立预测因素。除去氧肾上腺素外,升压药选择及剂量未预测DGF。

要点

  • 在脑死亡器官捐献者中,较高剂量的去氧肾上腺素是肾移植受者发生DGF的独立预测因素。
  • 除去氧肾上腺素外,其他升压药的选择及剂量未预测DGF。
  • 捐献者血清肌酐升高、年龄、肾捐献者特征指数和移植物冷缺血时间是DGF的独立预测因素。
  • 该研究为预后研究,证据等级为Level III。

适用人群与场景

  • 2012至2018年由9个器官获取与移植网络区域17个器官获取组织管理的脑死亡器官捐献者,且三个标准化时间点均至少接受一种升压药。
  • 对应的肾移植受者。

研究设计与关键结果

  • 研究类型:前瞻性观察研究;样本量:5554例肾移植受者和2985例脑死亡器官捐献者;17个器官获取组织,9个器官获取与移植网络区域。
  • 单因素分析显示捐献者血清肌酐、捐献者年龄、捐献者亚型、肾捐献者特征指数、移植物冷缺血时间、去氧肾上腺素剂量和多巴胺剂量与DGF相关。
  • 多因素分析后,捐献者血清肌酐升高、捐献者年龄、肾捐献者特征指数、移植物冷缺血时间和去氧肾上腺素剂量仍是DGF的独立预测因素。
  • 除去氧肾上腺素外,升压药选择及剂量未预测DGF。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究(预后研究),证据等级Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,较高剂量的去氧肾上腺素是DGF的独立预测因素;除去氧肾上腺素外,捐献者管理期间的升压药选择及剂量未预测DGF。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Delayed graft function (DGF), the need for dialysis in the first week following kidney transplant, affects approximately one quarter of deceased-donor kidney transplant recipients. Donor demographics, donor serum creatinine, and graft cold ischemia time are associated with DGF. However, there is no consensus on the optimal management of hemodynamic instability in organ donors after brain death (DBDs). Our objective was to determine the relationship between vasopressor selection during donor management and the development of DGF.

METHODS: Prospective observational data, including demographic and critical care parameters, were collected for all DBDs managed by 17 organ procurement organizations from nine Organ Procurement and Transplantation Network Regions between 2012 and 2018. Recipient outcome data were linked with donor data through donor identification numbers. Donor critical care parameters, including type of vasopressor and doses, were recorded at three standardized time points during donor management. The analysis included only donors who received at least one vasopressor at all three time points. Vasopressor doses were converted to norepinephrine equivalent doses and analyzed as continuous variables. Univariate analyses were conducted to determine the association between donor variables and DGF. Results were adjusted for known predictors of DGF using binary logistic regression.

RESULTS: Complete data were available for 5,554 kidney transplant recipients and 2,985 DBDs. On univariate analysis, donor serum creatinine, donor age, donor subtype, kidney donor profile index, graft cold ischemia time, phenylephrine dose, and dopamine dose were associated with DGF. After multivariable analysis, increased donor serum creatinine, donor age, kidney donor profile index, graft cold ischemia time, and phenylephrine dose remained independent predictors of DGF.

CONCLUSION: Higher doses of phenylephrine were an independent predictor of DGF. With the exception of phenylephrine, the selection and dose of vasopressor during donor management did not predict the development of DGF.

LEVEL OF EVIDENCE: Prognostic study, Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Swanson EA, Patel MS, Groat T, et al. Vasopressor selection during critical care management of brain dead organ donors and the effects on kidney graft function. J Trauma Acute Care Surg. 2020. PMID: 32459446. doi:10.1097/TA.0000000000002688

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。